Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222871 · ClinicalTrials.gov registry record · Phase 1
Treatment of Early Nasal Polyposis With Topical Triamcinolone
A Phase 1 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01222871: Clinical Trial Phase 1 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
NCT01222871 is a Phase 1 study that was terminated before completion, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01222871, a Phase 1 study, was terminated before completion, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.
Primary Outcome
nasal endoscopic exam findings at 2 weeks, 6 weeks and 12 weeks were not collected from any participant.
Interventions
- DRUG Triamcinolone
- DRUG Saline soaked sponge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Why NCT01222871 stopped before completion
NCT01222871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone is the first listed.
NCT01222871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01222871 about?
NCT01222871 is a clinical study titled "Treatment of Early Nasal Polyposis With Topical Triamcinolone". The purpose of this study is to compare the effectiveness of intranasal Triamcinolone delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked dressing, in the treatment and prevention of early nasal polyposis.
What is the current status of trial NCT01222871?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2010-07. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01222871?
The interventions under investigation include: Triamcinolone (DRUG), Saline soaked sponge (DRUG).
Who is sponsoring clinical trial NCT01222871?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01222871's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia